Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00775320 · ClinicalTrials.gov registry record

Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET

A clinical trial, sponsored by University of Oklahoma.

Terminated
Registry status
13
Enrollment target

NCT00775320 is a clinical trial that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00775320 was terminated before completion, sponsored by University of Oklahoma.

TERMINATED
Registry status
13 participants
Enrollment target

Study Summary

The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.

Interventions

  • PROCEDURE FLT-PET scan

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2008-10
Est. Completion 2010-08

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT00775320

The ClinicalTrials.gov registry entry for NCT00775320 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which FLT-PET scan is the first listed.

NCT00775320 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00775320 about?

NCT00775320 is a clinical study titled "Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET". The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.

What is the current status of trial NCT00775320?

This trial is currently terminated. The enrollment target is 13 participants. The study started on 2008-10. Estimated completion is 2010-08.

What interventions are being tested in trial NCT00775320?

The interventions under investigation include: FLT-PET scan (PROCEDURE).

Who is sponsoring clinical trial NCT00775320?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.